drugset / Trial / NCT05268692
Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP
RandomizedSequentialOpen-labelTreatment
Summary
The effect of neoadjuvant chemotherapy for pancreatic cancer was gradually established. However it has been not clarified which regimen of neoadjuvant treatment for pancreatic cancer is the best.
Timeline
- Start
- 2019-01-01
- Primary completion
- 2025-12-31
- Completion
- 2030-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gemcitabine | Small molecule | 800 mg/m2 | Intravenous |
| Comparator | Paclitaxel | Small molecule | 100 mg/m2 | Intravenous |
| Comparator | S-1 | Small molecule | 60 mg | Oral |
| Comparator | S-1 | Small molecule | 80 mg | Oral |
| Comparator | S-1 | Small molecule | 100 mg | Oral |